BioCardia granted US Patent No. 12,311,127 for Helix catheter delivery system

BioCardia, Inc.

Patent covers radial and trans-endocardial delivery catheter for biologic therapies.
Protects helical needle-tipped catheter platform; cited as safest and most efficient approach.
Helix system underlies CardiAMP Cell Therapy program for ischemic cardiomyopathies and refractory angina.
CEO notes work toward separate approvals of the therapy and the delivery system.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.